HeartFlow
Update in progressHTFL (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryHealth Information Services
HeartFlow, Inc. is a medical technology company providing non‑invasive tools to diagnose and manage coronary artery disease worldwide. The HeartFlow Platform uses AI and computational fluid dynamics to build a personalized 3D heart model from a single coronary CT angiography scan. It offers RoadMap Analysis, FFRCT Analysis to estimate blood flow and locate flow limitations, and Plaque Analysis to assess plaque burden and composition. Formerly Cardiovascular Simulation, Inc., renamed HeartFlow in 2009 and headquartered in Mountain View, California.
Company score
- Sentiment
- 0.55
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.32
- Governance
- 0.20
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.14
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.34
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!